Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Talking it out: psychotherapy may ease depression in dialysis patients

NCT ID NCT06839287

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tested whether interpersonal psychotherapy-based counseling could help people on hemodialysis adjust to their illness and reduce depression. 48 adults who had been on dialysis for at least 6 months were split into two groups: one received the counseling for 8 weeks, the other got routine care. Researchers measured changes in how well patients adapted to their chronic disease and their depression levels.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
interpersonal psychotherapy-based counseling
What this could lead to
If effective, this counseling approach could become a standard way to help hemodialysis patients cope better and feel less depressed.
What could go wrong
This is a small, completed study with only 48 participants, so results may not apply to everyone. The intervention is talk therapy, not a drug, so benefits may vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

48 people

The number who actually took part.

Started

Mar 2025

Finished

Sep 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * • 18 years of age or older, * Hemodialysis treatment for at least 6 months, * Having no problem communicating in Turkish, * No hearing problems and cognitive impairment, * Openness to cooperation, * Not diagnosed with major depression according to DSM-V and ICD-11, * Not having an additional mental disorder, * Not receiving any therapy or treatment, * Receiving hemodialysis treatment at the center 3 days a week, * Do not take care of yourself, * Scoring 10 and above on the Beck Depression Inventory (scores of 10 and above indicate that the participant has depressive symptoms) * Patients who voluntarily agree to participate in the study will be included. Exclusion Criteria: * \- Having a neurological or psychiatric illness that may interfere with reading and understanding the data collection tools, * Have received or are receiving any therapy or treatment, * A score of 10 or less on the Beck Depression Inventory, * Having problems in speaking/understanding Turkish, * Changing cities during research, * Don't want to leave the research, * Receiving a psychiatric diagnosis during research, * Starting therapy or treatment during the research, * Hospitalization during research, * Failure to attend the treatment for 2 consecutive sessions,

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for End-stage renal disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Başkent University

    Ankara, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.